The Role of Molecular Imaging in a Muscle-Invasive Bladder Cancer Patient: A Narrative Review in the Era of Multimodality Treatment
Open Access
- 11 May 2021
- journal article
- review article
- Published by MDPI AG in Diagnostics
- Vol. 11 (5) , 863
Abstract
Diagnostic imaging in bladder cancer plays an important role since it is needed from pretreatment staging to follow-up, but a morphological evaluation performed with both CT and MRI showed low sensitivities and specificities in detecting pathologic lymph nodes, due to the occurrence of false positive results. Implementation of functional information provided by PET/CT could be a determinant in the management of patients with muscle-invasive bladder cancer. A focus on the role of 18F-FDG PET/CT and alternative tracers in patients with muscle-invasive bladder cancer is provided in this analysis in order to outline its potential applications in staging settings and response evaluation after neoadjuvant chemotherapy.Keywords
This publication has 76 references indexed in Scilit:
- Role of fluorodeoxyglucose positron emission tomography ( FDG PET )‐computed tomography ( CT ) in the staging of bladder cancerBJU International, 2013
- Clinical value of FDG PET or PET/CT in urinary bladder cancer: A systemic review and meta-analysisEuropean Journal of Radiology, 2012
- PET/MRI and the revolution of the third eyeEuropean Journal of Nuclear Medicine and Molecular Imaging, 2012
- Role of Diffusion-Weighted Magnetic Resonance Imaging in Predicting Sensitivity to Chemoradiotherapy in Muscle-Invasive Bladder CancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2012
- Role of magnetic resonance imaging in bladder cancer: current status and emerging techniquesBJU International, 2012
- Comparison of 11 C-Choline With 18 F-FDG in Positron Emission Tomography/Computerized Tomography for Staging Urothelial Carcinoma: A Prospective StudyJournal of Urology, 2011
- Initial Results with 11C-Acetate Positron Emission Tomography/Computed Tomography (PET/CT) in the Staging of Urinary Bladder CancerMolecular Imaging and Biology, 2011
- Clinical Value of Fluorine-18 2-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography/Computed Tomography in Bladder CancerJournal of Clinical Oncology, 2010
- Initial Experience of Diffusion-weighted Magnetic Resonance Imaging to Assess Therapeutic Response to Induction Chemoradiotherapy Against Muscle-invasive Bladder CancerUrology, 2010
- Forced diuresis and dual-phase 18F-fluorodeoxyglucose-PET/CT scan for restaging of urinary bladder cancersIndian Journal of Radiology and Imaging, 2010